{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:51:20Z","timestamp":1774896680462,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL-65998"],"award-info":[{"award-number":["HL-65998"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL-111775"],"award-info":[{"award-number":["HL-111775"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bcp.2019.04.021","type":"journal-article","created":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T14:24:55Z","timestamp":1555770295000},"page":"347-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Sulodexide promotes arterial relaxation via endothelium-dependent nitric oxide-mediated pathway"],"prefix":"10.1016","volume":"166","author":[{"given":"Joseph D.","family":"Raffetto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorella","family":"Calanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Mattana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raouf A.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2019.04.021_b0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2174\/157016109788340668","article-title":"Current management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapies","volume":"7","author":"Mangiafico","year":"2009","journal-title":"Curr. Vascular Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.021_b0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0049-3848(84)90224-X","article-title":"Flow through a venous valve and its implication for thrombus formation","volume":"36","author":"Karino","year":"1984","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bcp.2019.04.021_b0015","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2147\/VHRM.S4621","article-title":"The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants","volume":"5","author":"Blann","year":"2009","journal-title":"Vascular Health Risk Manage."},{"key":"10.1016\/j.bcp.2019.04.021_b0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000073586","article-title":"Dermatan sulphate as an antithrombotic drug","volume":"32","author":"Nenci","year":"2002","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"10.1016\/j.bcp.2019.04.021_b0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/JBM.S10558","article-title":"Use of sulodexide in patients with peripheral vascular disease","volume":"1","author":"Lasierra-Cirujeda","year":"2010","journal-title":"J. Blood Med."},{"key":"10.1016\/j.bcp.2019.04.021_b0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1527-3466.2006.00214.x","article-title":"Sulodexide: a renewed interest in this glycosaminoglycan","volume":"24","author":"Lauver","year":"2006","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.bcp.2019.04.021_b0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpba.2018.04.012","article-title":"Fine structural characterization of sulodexide","volume":"156","author":"Veraldi","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bcp.2019.04.021_b0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2007-995831","article-title":"Pharmacological actions of sulodexide","volume":"24","author":"Ofosu","year":"1998","journal-title":"Semin. Thromb. Hemost."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2019.04.021_b0045","first-page":"49","article-title":"Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative","volume":"19","author":"Callas","year":"1993","journal-title":"Suleparoide. Semin Thromb. Hemost"},{"key":"10.1016\/j.bcp.2019.04.021_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1128(199801)18:1<1::AID-MED1>3.0.CO;2-4","article-title":"Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide","volume":"18","author":"Harenberg","year":"1998","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcp.2019.04.021_b0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02591420","article-title":"Antithrombotic and thrombolytic activity of sulodexide in rats","volume":"22","author":"Barbanti","year":"1992","journal-title":"Int. J. Clin. Lab. Res."},{"key":"10.1016\/j.bcp.2019.04.021_b0060","first-page":"1891","article-title":"Sulodexide for the prevention of recurrent venous thromboembolism: the sulodexide in secondary prevention of recurrent deep vein thrombosis (SURVET) Study: a multicenter, randomized, double-blind","volume":"132","author":"Andreozzi","year":"2015","journal-title":"Placebo-Controlled Trial. Circ."},{"key":"10.1016\/j.bcp.2019.04.021_b0065","first-page":"49","article-title":"Development and use of sulodexide in vascular diseases: implications for treatment","volume":"8","author":"Coccheri","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bcp.2019.04.021_b0070","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1055\/s-0037-1613116","article-title":"Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers","volume":"87","author":"Coccheri","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcp.2019.04.021_b0075","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/000331979905001102","article-title":"Treatment of venous leg ulcers with sulodexide","volume":"50","author":"Scondotto","year":"1999","journal-title":"Angiology"},{"key":"10.1016\/j.bcp.2019.04.021_b0080","first-page":"263","article-title":"Biological and clinical effects of sulodexide in arterial disorders and diseases","volume":"33","author":"Coccheri","year":"2014","journal-title":"Int. Angiol."},{"key":"10.1016\/j.bcp.2019.04.021_b0085","first-page":"255","article-title":"Role of sulodexide in the treatment of CVD","volume":"33","author":"Andreozzi","year":"2014","journal-title":"Int. Angiol."},{"key":"10.1016\/j.bcp.2019.04.021_b0090","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/bcp.12722","article-title":"The blood pressure lowering potential of sulodexide \u2013 a systematic review and meta-analysis","volume":"80","author":"Olde Engberink","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.021_b0095","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/bcp.13062","article-title":"Blood pressure-lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies","volume":"82","author":"Olde Engberink","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.021_b0100","doi-asserted-by":"crossref","first-page":"4989847","DOI":"10.1155\/2017\/4989847","article-title":"Sulodexide protects renal tubular epithelial cells from oxidative stress-induced injury via upregulating Klotho expression at an early stage of diabetic kidney disease","volume":"2017","author":"Liu","year":"2017","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bcp.2019.04.021_b0105","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/ndt\/gfr370","article-title":"Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion","volume":"27","author":"Pletinck","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bcp.2019.04.021_b0110","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1016\/j.bbadis.2018.09.022","article-title":"Electronegative LDL induces MMP-9 and TIMP-1 release in monocytes through CD14 activation: inhibitory effect of glycosaminoglycan sulodexide","volume":"1864","author":"Ligi","year":"2018","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.bcp.2019.04.021_b0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.trsl.2008.12.007","article-title":"Sulodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity","volume":"153","author":"Ciszewicz","year":"2009","journal-title":"Transl. Res."},{"key":"10.1016\/j.bcp.2019.04.021_b0120","first-page":"149","article-title":"Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research","volume":"3","author":"Mannello","year":"2011","journal-title":"Am. J. Trans. Res."},{"key":"10.1016\/j.bcp.2019.04.021_b0125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2174\/1570161111311030010","article-title":"Glycosaminoglycan sulodexide inhibition of MMP-9 gelatinase secretion and activity: possible pharmacological role against collagen degradation in vascular chronic diseases","volume":"11","author":"Mannello","year":"2013","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.021_b0130","doi-asserted-by":"crossref","first-page":"CR222-6","DOI":"10.12659\/MSM.881719","article-title":"Sulodexide reduces senescence-related changes in human endothelial cells","volume":"17","author":"Suminska-Jasinska","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bcp.2019.04.021_b0135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2478\/ams-2013-0016","article-title":"Sulodexide modifies intravascular homeostasis what affects function of the endothelium","volume":"58","author":"Polubinska","year":"2013","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.bcp.2019.04.021_b0140","first-page":"122","article-title":"Evidence from endothelium of gastric absorption of heparin and of dextran sulfates 8000","volume":"117","author":"Jaques","year":"1991","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bcp.2019.04.021_b0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-2007-1002751","article-title":"Pharmacokinetic studies of standard unfractionated heparin, and low molecular weight heparins in the rabbit","volume":"14","author":"Boneu","year":"1988","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bcp.2019.04.021_b0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11906-999-0078-6","article-title":"Nitric oxide, nitric oxide synthase, and hypertensive vascular disease","volume":"1","author":"Busse","year":"1999","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.bcp.2019.04.021_b0155","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.phrs.2003.11.012","article-title":"Prostacyclin and endothelium-dependent hyperpolarization","volume":"49","author":"Parkington","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2019.04.021_b0160","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/01.ATV.0000217611.81085.c5","article-title":"Endothelium-derived hyperpolarizing factor: where are we now?","volume":"26","author":"Feletou","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2019.04.021_b0165","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/bph.12225","article-title":"Enhanced endothelin receptor type B-mediated vasodilation and underlying [Ca(2)(+)]i in mesenteric microvessels of pregnant rats","volume":"169","author":"Mazzuca","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.021_b0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/jpet.114.219865","article-title":"Estrogen receptor subtypes mediate distinct microvascular dilation and reduction in [Ca2+]I in mesenteric microvessels of female rat","volume":"352","author":"Mazzuca","year":"2015","journal-title":"J. Pharm. Exp. Therapeutics"},{"key":"10.1016\/j.bcp.2019.04.021_b0175","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/HYPERTENSIONAHA.114.03315","article-title":"Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy","volume":"64","author":"Mazzuca","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2019.04.021_b0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/01.HYP.35.1.367","article-title":"Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat","volume":"35","author":"Crews","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2019.04.021_b0185","first-page":"236","article-title":"Glycosaminoglycan sulodexide modulates inflammatory pathways in chronic venous disease","volume":"33","author":"Mannello","year":"2014","journal-title":"Int. Angiol."},{"key":"10.1016\/j.bcp.2019.04.021_b0190","first-page":"189","article-title":"Sulodexide oral administration influences blood viscosity and fibrinolysis","volume":"18","author":"Crepaldi","year":"1992","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.bcp.2019.04.021_b0195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/030006058501300106","article-title":"The effectiveness of glycosaminoglycans in peripheral vascular disease therapy: a clinical and experimental trial","volume":"13","author":"Corsi","year":"1985","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bcp.2019.04.021_b0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1185\/03007999309111537","article-title":"Pharmacodynamic effects of single and repeated doses of oral sulodexide in healthy volunteers. A placebo-controlled study with an enteric-coated formulation","volume":"13","author":"Mauro","year":"1993","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bcp.2019.04.021_b0205","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMra055289","article-title":"Chronic venous disease","volume":"355","author":"Bergan","year":"2006","journal-title":"New England J. Med."},{"key":"10.1016\/j.bcp.2019.04.021_b0210","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week","volume":"72","author":"Libby","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2019.04.021_b0215","first-page":"140","article-title":"Sulodexide reduces the inflammatory reaction and senescence of endothelial cells in conditions involving chronic venous disease","volume":"35","author":"Urbanek","year":"2016","journal-title":"Int. Angiol."},{"key":"10.1016\/j.bcp.2019.04.021_b0220","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1159\/000453157","article-title":"Sulodexide reduces the proinflammatory effect of serum from patients with peripheral artery disease in human arterial endothelial cells","volume":"40","author":"Sosinska","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bcp.2019.04.021_b0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0049-3848(84)90108-7","article-title":"Antithrombotic activity of a glycosaminoglycan (sulodexide) in rats","volume":"34","author":"Andriuoli","year":"1984","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bcp.2019.04.021_b0230","first-page":"15","article-title":"Effect of heparin-like compounds on the in vitro proliferation and protein synthesis of various cell types","volume":"39","author":"Tiozzo","year":"1989","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.bcp.2019.04.021_b0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/jpet.103.061192","article-title":"Role of alpha-adrenergic receptors in the effect of the beta-adrenergic receptor ligands, CGP 12177, bupranolol, and SR 59230A, on the contraction of rat intrapulmonary artery","volume":"309","author":"Leblais","year":"2004","journal-title":"J. Pharm. Exp. Therapeutics"},{"key":"10.1016\/j.bcp.2019.04.021_b0240","doi-asserted-by":"crossref","first-page":"C399","DOI":"10.1152\/ajpcell.1990.258.3.C399","article-title":"cGMP-dependent protein kinase mediates the reduction of Ca2+ by cAMP in vascular smooth muscle cells","volume":"258","author":"Lincoln","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bcp.2019.04.021_b0245","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.amjcard.2017.06.012","article-title":"The nitric oxide pathway in pulmonary vascular disease","volume":"120","author":"Klinger","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bcp.2019.04.021_b0250","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.bcp.2005.07.017","article-title":"Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension","volume":"70","author":"Salamanca","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.021_b0255","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/pr.111.004770","article-title":"Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn","volume":"64","author":"Majed","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2019.04.021_b0260","doi-asserted-by":"crossref","first-page":"91350","DOI":"10.18632\/oncotarget.20518","article-title":"Sulodexide recovers endothelial function through reconstructing glycocalyx in the balloon-injury rat carotid artery model","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2019.04.021_b0265","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/HYPERTENSIONAHA.110.156877","article-title":"Heparin induces rat aorta relaxation via integrin-dependent activation of muscarinic M3 receptors","volume":"56","author":"Paredes-Gamero","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2019.04.021_b0270","first-page":"243","article-title":"Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects","volume":"33","author":"Masola","year":"2014","journal-title":"Int. Angiol."},{"key":"10.1016\/j.bcp.2019.04.021_b0275","doi-asserted-by":"crossref","first-page":"R233","DOI":"10.1152\/ajpregu.00338.2003","article-title":"Gender, sex hormones, and vascular tone","volume":"286","author":"Orshal","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bcp.2019.04.021_b0280","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/01.RES.81.5.885","article-title":"17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization","volume":"81","author":"Caulin-Glaser","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2019.04.021_b0285","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1172\/JCI5347","article-title":"Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen","volume":"103","author":"Chen","year":"1999","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bcp.2019.04.021_b0290","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1074\/jbc.M005036200","article-title":"Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells","volume":"276","author":"Hisamoto","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2019.04.021_b0295","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.RES.87.8.677","article-title":"Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells","volume":"87","author":"Haynes","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2019.04.021_b0300","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/jsre.1997.5106","article-title":"Nitric oxide inhibition simulates the enhancement of alpha 1 agonist-induced vasoconstriction in diabetes","volume":"70","author":"Dresner","year":"1997","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bcp.2019.04.021_b0305","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1476-5381.1996.tb15255.x","article-title":"Effect of NG-nitro-L-arginine methylester (L-NAME) on functional and biochemical alpha 1-adrenoceptor-mediated responses in rat blood vessels","volume":"117","author":"Tabernero","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.021_b0310","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.niox.2017.10.003","article-title":"Residual NO modulates contractile responses and membrane potential in isolated rat mesenteric arteries","volume":"71","author":"Kiroglu","year":"2017","journal-title":"Nitric oxide"},{"key":"10.1016\/j.bcp.2019.04.021_b0315","doi-asserted-by":"crossref","first-page":"C1454","DOI":"10.1152\/ajpcell.00066.2003","article-title":"Ca2+ antagonist-insensitive coronary smooth muscle contraction involves activation of epsilon-protein kinase C-dependent pathway","volume":"285","author":"Dallas","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bcp.2019.04.021_b0320","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bcp.2018.02.012","article-title":"Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease","volume":"153","author":"Liu","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.021_b0325","doi-asserted-by":"crossref","first-page":"48227","DOI":"10.1074\/jbc.M205867200","article-title":"Heparin and heparan sulfate disaccharides bind to the exchanger inhibitor peptide region of Na+\/Ca2+ exchanger and reduce the cytosolic calcium of smooth muscle cell lines. Requirement of C4\u2013C5 unsaturation and 1\u2013> 4 glycosidic linkage for activity","volume":"277","author":"Shinjo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2019.04.021_b0330","doi-asserted-by":"crossref","first-page":"H393","DOI":"10.1152\/ajpheart.00247.2002","article-title":"Enhanced [Ca2+]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure","volume":"284","author":"Murphy","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2019.04.021_b0335","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/bs.apha.2016.06.002","article-title":"Protein kinase C as regulator of vascular smooth muscle function and potential target in vascular disorders","volume":"78","author":"Ringvold","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.021_b0340","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/1076029614533143","article-title":"The efficacy of sulodexide in the prevention of postthrombotic syndrome","volume":"20","author":"Luzzi","year":"2014","journal-title":"Clin. Appl. Thromb. Hemost."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521930156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521930156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T23:41:13Z","timestamp":1607298073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629521930156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":68,"alternative-id":["S000629521930156X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.04.021","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulodexide promotes arterial relaxation via endothelium-dependent nitric oxide-mediated pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}